Infectious Disease & Vaccines
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 MRK | Merck & Co., Inc. | $293.2b | $120.66 | +0.3% | 16.0M |
 GILD | Gilead Sciences Inc | $166.9b | $129.00 | -0.1% | 15.4M |
 PFE | Pfizer Inc. | $149.2b | $25.93 | +0.9% | 32.2M |
 MRNA | Moderna, Inc. Common Stock | $18.7b | $47.41 | -8.1% | 6.1M |
 SMMT | Summit Therapeutics Inc. Common Stock | $13.6b | $14.75 | -0.6% | 6.5M |
 PCVX | Vaxcyte, Inc. Common Stock | $7.4b | $47.36 | -2.9% | 1.1M |
 BCRX | BioCryst Pharmaceuticals Inc | $2.3b | $8.40 | -0.8% | 2.5M |
 NVAX | Novavax Inc | $1.8b | $9.48 | -7.0% | 4.6M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.6b | $8.64 | -5.6% | 1.3M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $4.24 | -2.5% | 1.1M |
 CRMD | CorMedix Inc. | $0.7b | $8.36 | -2.1% | 906.2K |
 ASMB | Assembly Biosciences, Inc | $0.5b | $22.89 | -5.1% | 130.6K |
 EBS | Emergent Biosolutions, Inc. | $470.6m | $7.98 | -5.5% | 701.5K |
 ENTA | Enanta Pharmaceuticals, Inc | $382.7m | $11.26 | -4.0% | 135.1K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $373.7m | $4.24 | -4.1% | 217.6K |
 IVVD | Invivyd, Inc. Common Stock | $335.9m | $1.01 | -8.6% | 5.0M |
 SIGA | SIGA Technologies Inc. | $335.7m | $4.30 | -2.8% | 551.0K |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $299.9m | $7.50 | -2.5% | 36.8K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $225.1m | $7.30 | -9.2% | 412.9K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $196.6m | $11.05 | -7.0% | 481.1K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $163.9m | $2.83 | -5.0% | 756.3K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $155.9m | $3.84 | -7.9% | 178.2K |
 INO | Inovio Pharmaceuticals, Inc. | $107.8m | $1.06 | -8.2% | 3.3M |
 XBIT | XBiotech Inc | $73.8m | $2.37 | -0.2% | 33.2K |
 MCRB | Seres Therapeutics, Inc. | $70.9m | $6.59 | -3.8% | 280.9K |
 ZTEK | Zentek Ltd. Common Stock | $63.8m | $0.53 | 0.0% | 62.3K |
 IBO | Impact BioMedical, Inc. | $56.1m | $0.58 | +2.7% | 76.7K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $45.0m | $4.47 | -7.7% | 81.0K |
 NNVC | NanoViricides Inc. | $40.5m | $1.44 | -4.0% | 682.9K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.3m | $4.92 | -7.9% | 128.4K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $33.1m | $10.26 | +4.0% | 100.6K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $32.1m | $13.22 | +3.3% | 48.2K |
 CODX | Co-Diagnostics, Inc. Common Stock | $31.4m | $5.65 | -1.9% | 669.5K |
 TRAW | Traws Pharma, Inc. Common Stock | $22.1m | $1.38 | -6.8% | 354.5K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $15.4m | $0.99 | -6.0% | 160.2K |
 MBRX | Moleculin Biotech, Inc. | $14.9m | $2.40 | -4.4% | 225.9K |
 SNGX | Soligenix, Inc. Common Stock | $13.5m | $0.44 | -7.6% | 1.5M |
 PHGE | BiomX Inc. | $12.8m | $0.73 | -12.5% | 420.1K |
 GOVX | GeoVax Labs, Inc. New | $10.7m | $1.64 | -8.7% | 652.1K |
 IMNN | Imunon, Inc. Common Stock | $9.2m | $2.06 | -2.1% | 84.6K |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $8.5m | $1.68 | -5.1% | 97.0K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $8.4m | $0.99 | -8.8% | 1.2M |
 XBIO | Xenetic Biosciences, Inc. | $7.2m | $3.01 | -12.2% | 12.1K |
 SCYX | SCYNEXIS, Inc. | $7.0m | $4.65 | -4.7% | 65.5K |
 AIM | AIM ImmunoTech Inc. | $5.9m | $0.50 | -14.9% | 7.7M |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $4.0m | $1.43 | -6.9% | 38.7K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 AEMD | AETHLON MEDICAL INC | $3.5m | $1.98 | -7.0% | 194.9K |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $1.4m | $0.21 | +4.9% | 1.7M |
 SBFM | Sunshine Biopharma Inc. | $410.8k | $2.50 | -2.7% | 283.0K |